| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.085 | 0.06 |